Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Physiol Res ; 64(Suppl 2): S121-33, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26680473

RESUMO

The local concentration of glucocorticoids is intensively regulated by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD 1). Human 11beta-HSD 1 also reversibly catalyzes the inter-conversion of 7alpha-hydroxy- and 7beta-hydroxy-dehydroepiandrosterone (DHEA) into 7-oxo-DHEA. The cohort of 282 obese adolescents, 154 girls (median age 15.31 years, range 14.17-16.68 years) and 128 boys (median age 14.95 years, range 13.87-16.16 years), BMI (Body Mass Index) >90th percentile was examined. In samples collected before and after one month of reductive diet therapy, circulating levels of steroids were analyzed by liquid chromatography-tandem mass spectrometry and radioimmunoassay methods. The model of the treatment efficacy prediction was calculated. A significant reduction in circulating levels of cortisone, E2 and increased levels of 7beta-hydroxy-DHEA after the reductive treatment was observed. Levels of cortisol, DHEA, DHT sustained without any significant change. The predictive Orthogonal Projections to Latent Structures (OPLS) model explained 20.1 % of variability of BMI, z-score change by the basal levels of 7alpha-hydroxy-DHEA, DHEA, cortisol and E2 as the strongest predictors. Reduced levels of circulating cortisone and reduced ratios of oxygenated/reduced metabolites reflect increased reductase activity of 11beta-HSD 1 with reduced BMI, z-score. We hypothesize whether these changes can be attributed to the altered activity of 11beta-HSD 1 in the liver.


Assuntos
11-beta-Hidroxiesteroide Desidrogenase Tipo 1/sangue , Desidroepiandrosterona/sangue , Dieta Redutora/tendências , Obesidade/sangue , Obesidade/terapia , Adolescente , Biomarcadores/sangue , Estudos de Coortes , Feminino , Humanos , Fígado/metabolismo , Masculino , Resultado do Tratamento
2.
Physiol Res ; 64(Suppl 2): S227-36, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26680484

RESUMO

Normal pressure hydrocephalus (NPH) is one of a few treatable conditions of cognitive decline affecting predominately elderly people. Treatment, commonly based on the ventriculoperitoneal shunt insertion, leads to a partial or complete correction of patient's state, although its effect does not unfortunately always last. The aim of our study was to observe the changes of homocysteine and selected steroids and neurosteroids and follow-up the patients with respect to the duration of the NPH-related dementia improvement. The cerebrospinal fluid and plasma levels of cortisol, cortisone, dehydroepiandrosterone (DHEA), 7alpha-hydroxy-DHEA, 7beta-hydroxy-DHEA, 7-oxo-DHEA, 16alpha-hydroxy-DHEA (all LC-MS/MS), DHEA-sulphate (DHEAS) (radioimmunoassay) and homocysteine (gas chromatography) were determined in NPH-diagnosed subjects before, during and 6, 12 and 24 months after shunt insertion. The cognitive functions ameliorated after shunt insertion and remain improved within 2 years. Changes in cerebrospinal fluid DHEAS, DHEA and its ratio, cortisone/cortisol and 16alpha-hydroxy-DHEA and plasma DHEAS, 7beta-hydroxy-DHEA, cortisone/cortisol and homocysteine were found. Mentioned changes may contribute to the clarification of NPH pathogenesis. Altered neurosteroids levels are possible indicators to be utilized in the follow-up of NPH subjects. Moreover, plasma homocysteine may serve as an early indicator of NPH-related dementia.


Assuntos
Homocisteína/sangue , Homocisteína/líquido cefalorraquidiano , Hidrocefalia de Pressão Normal/sangue , Hidrocefalia de Pressão Normal/líquido cefalorraquidiano , Neurotransmissores/sangue , Neurotransmissores/líquido cefalorraquidiano , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Cortisona/sangue , Cortisona/líquido cefalorraquidiano , Desidroepiandrosterona/sangue , Desidroepiandrosterona/líquido cefalorraquidiano , Feminino , Humanos , Hidrocefalia de Pressão Normal/cirurgia , Hidrocortisona/sangue , Hidrocortisona/líquido cefalorraquidiano , Masculino , Resultado do Tratamento
3.
Physiol Res ; 64(Suppl 2): S259-64, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26680488

RESUMO

Hormones exert many actions in the brain. Their access and effects in the brain are regulated by the blood-brain barrier (BBB). Hormones as other substances may enter the brain and vice versa either by paracellular way requiring breaching tight junctions stitching the endothelial cells composing the BBB, or by passage through the cells (transcellular way). Hormones influence both ways through their receptors, both membrane and intracellular, present on/in the BBB. In the review the main examples are outlined how hormones influence the expression and function of proteins forming the tight junctions, as well as how they regulate expression and function of major protein transporters mediating transport of various substances including hormone themselves.


Assuntos
Barreira Hematoencefálica/citologia , Barreira Hematoencefálica/fisiologia , Hormônios/metabolismo , Animais , Encéfalo/citologia , Encéfalo/metabolismo , Células Endoteliais/metabolismo , Humanos , Transporte Proteico/fisiologia
4.
Physiol Res ; 64(Suppl 2): S283-90, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26680491

RESUMO

Cytokines are widely known mediators of inflammation accompanying many neurodegenerative disorders including normal pressure hydrocephalus (NPH). NPH is caused by impaired cerebrospinal fluid (CSF) reabsorption and treated by surgical shunt insertion. The diagnostics is still complicated and the shunt effect is not durable; after several years, dementia may develop. In the clinical practice, biomarkers support the diagnostics as well as the further time course of many neurodegenerative diseases. Until recently, no reliable biomarker for NPH was evaluated. The attempt of this review was to make a survey concerning cytokines as possible NPH markers. Among all reviewed cytokines, the most promising are CSF IL-10 and IL-33, enabling to follow-up the disease progression and monitoring the effectiveness of the shunt insertion.


Assuntos
Citocinas/sangue , Hidrocefalia de Pressão Normal/sangue , Hidrocefalia de Pressão Normal/diagnóstico , Biomarcadores/sangue , Derivações do Líquido Cefalorraquidiano/tendências , Seguimentos , Humanos , Hidrocefalia de Pressão Normal/cirurgia , Mediadores da Inflamação/sangue
5.
Physiol Res ; 64(Suppl 2): S303-11, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26680493

RESUMO

The general population is potentially exposed to many chemicals that can affect the endocrine system. These substances are called endocrine disruptors (EDs), and among them bisphenol A (BPA) is one of the most widely used and well studied. Nonetheless, there are still no data on simultaneous measurements of various EDs along with steroids directly in the seminal fluid, where deleterious effects of EDs on spermatogenesis and steroidogenesis are assumed. We determined levels of BPA and 3 estrogens using LC-MS/MS in the plasma and seminal plasma of 174 men with different degrees of infertility. These men were divided according their spermiogram values into 4 groups: (1) healthy men, and (2) slightly, (3) moderate, and (4) severely infertile men. Estradiol levels differed across the groups and body fluids. Slightly infertile men have significantly higher BPA plasma and seminal plasma levels in comparison with healthy men (p<0.05 and p<0.01, respectively). Furthermore, seminal BPA, but not plasma BPA, was negatively associated with sperm concentration and total sperm count (-0.27; p<0.001 and -0.24; p<0.01, respectively). These findings point to the importance of seminal plasma in BPA research. Overall, a disruption of estrogen metabolism was observed together with a weak but significant impact of BPA on sperm count and concentration.


Assuntos
Compostos Benzidrílicos/metabolismo , Estrogênios/metabolismo , Infertilidade Masculina/diagnóstico , Infertilidade Masculina/metabolismo , Fenóis/metabolismo , Sêmen/metabolismo , Adulto , Compostos Benzidrílicos/sangue , Biomarcadores/sangue , Biomarcadores/metabolismo , Estrogênios/sangue , Humanos , Infertilidade Masculina/sangue , Masculino , Fenóis/sangue , Contagem de Espermatozoides/métodos
6.
Physiol Res ; 63(4): 521-7, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24908094

RESUMO

Increased homocysteine levels in serum are typical features of neurodegenerative brain diseases including hydrocephalus. The most frequent therapeutic approach consists of the insertion of a shunt, connecting the brain ventricles to an alternative drainage site. To decide whether the patient should undergo this, the lumbar drainage test is usually carried out to distinguish patients who can benefit from the shunt insertion. In searching for other potential biochemical markers for shunt indication we determined homocysteine levels in CSF during the lumbar drainage test. Homocysteine in CSF was measured during the 5-day lumbar drainage test in 27 patients with normal-pressure hydrocephalus (NPH) and in 25 patients with excluded hydrocephalus. A novelized gas chromatography method with flame ionization detection (GC-FID) was developed and evaluated. During the first two days of lumbar drainage, the levels of CSF homocysteine in NPH patients were significantly higher compared to the controls, while on the fifth day, the homocysteine levels in patients with hydrocephalus reached the level of controls. Determination of CSF homocysteine in patients with confirmed or suspected hydrocephalus may serve as an independent marker for deciding on their further treatment strategy.


Assuntos
Homocisteína/líquido cefalorraquidiano , Hidrocefalia/líquido cefalorraquidiano , Hidrocefalia/cirurgia , Biomarcadores/líquido cefalorraquidiano , Calibragem , Derivações do Líquido Cefalorraquidiano , Cromatografia Gasosa/métodos , Feminino , Ionização de Chama , Humanos , Limite de Detecção , Masculino , Reprodutibilidade dos Testes , Resultado do Tratamento
7.
Ceska Gynekol ; 77(1): 10-4, 2012 Feb.
Artigo em Tcheco | MEDLINE | ID: mdl-22536634

RESUMO

OBJECTIVE: Comparison of phytoestrogen treatment efficacy in menopausal women with and without ability to metabolise phytoestrogens. DESIGN: Clinical trial. SETTING: Department of Obstetrics and Gynaecology, Regional Hospital, Mlada Boleslav. METHODS: 28 menopausal women were treated with phytoestrogens in dose 80 mg daily. Before start and after finishing of treatment urinary concentrations of active metabolite S-equol were measured using ELISA method. Similarly before and after treatment Kupperman's index was measured. Patients with urinary concentrations of S-equol above 1 ng/ml were considered as S-equol producers, remaining patients formed control group. RESULTS: 16 out of 28 women were considered as S-equol producers, remainig 12 as a non-producers. Initial urinary concentrations of S-equol were 0.34 +/- 0.37 ng/ml in producers group and 0.29 +/- 0.30 ng/ml in non-producers. After finishing of therapy urinary concentration of S-equol increased to 10.67 +/- 11.57 ng/ml (p = 0.002) in producers group and 0.34 +/- 0.30 ng/ml (p = 0.701) in non-producers. Kupperman's index values were 23.44 +/- 11.57 in producers group and 17.25 +/- 7.78 in non-producers. After therapy value of Kupperman's index decreased to 14.44 +/- 9.97 (p = 0.003) in producers and to 12.00 +/- 7.18 (p = 0.100) in non-producers. No correlation between improvement in Kupperman's index and urinary concentration of S-equol after therapy was found similarly as between urinary concentration of S-equol before and after therapy in producents group. CONCLUSION: Significant phytoestrogen treatment effect in menopausal women producing S-equol was proven. Testing method for S-equol production introduced by our team togehter with suggested threshold urine concentration level of 1 ng/ml allows precise distinction of producers and non-producers of S-equol and subsequently to predict better treatment effect of phytoestrogens.


Assuntos
Equol/urina , Receptor beta de Estrogênio/agonistas , Menopausa/efeitos dos fármacos , Fitoestrógenos/uso terapêutico , Feminino , Humanos , Menopausa/urina
8.
Physiol Res ; 61(2): 221-5, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22292719

RESUMO

In order to assess whether intratesticular hormone content may be helpful for prediction of successful conception in men with fertility problems, five sex steroids, testosterone, dihydrotestosterone, androstenedione, estradiol and, for the first time epitestosterone, were measured in testicular tissue obtained by surgical retrieval from total 84 men. The group consisted of non-obstructive azoospermic men, aged 21-67 years who attended the centre for in vitro fertilization. Steroids after ether extraction and solvent partition were separated by high performance liquid chromatography and then measured by specific radioimmunoassays. The values varied considerably with means ± S.D. 2.43±2.47, 0.27±0.24, 0.080±0.13, 0.071±0.089 and 0.31±0.27 for testosterone, dihydrotestosterone, androstenedione, estradiol and epitestosterone, respectively.


Assuntos
Hormônios Esteroides Gonadais/análise , Testículo/química , Adulto , Idoso , Androstenodiona/análise , Azoospermia/metabolismo , Di-Hidrotestosterona/análise , Epitestosterona/análise , Estradiol/análise , Humanos , Masculino , Pessoa de Meia-Idade , Radioimunoensaio , Testículo/metabolismo , Testosterona/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA